MoneyWorks4Me

Marksans Pharma - Quaterly Results

19 May 2025 Evaluate
The sales surged to Rs. 2993.57 millions, up 32.93% for the March 2025 quarter as against Rs. 2251.96 millions during the corresponding quarter previous year.Profit saw a slight increase of 13.93%to Rs. 375.91  millions from Rs. 329.94 millions.Operating profit for the quarter ended March 2025 rose to 583.91 millions as compared to 460.99 millions of corresponding quarter ended March 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 2993.57 2251.96 32.93 11743.74 8532.73 37.63 11743.74 8532.73 37.63
Other Income 78.17 121.94 -35.89 698.34 620.73 12.50 698.34 620.73 12.50
PBIDT 583.91 460.99 26.66 2738.85 2020.08 35.58 2738.85 2020.08 35.58
Interest 3.11 2.28 36.40 11.74 9.88 18.83 11.74 9.88 18.83
PBDT 580.80 458.71 26.62 2727.11 2010.20 35.66 2727.11 2010.20 35.66
Depreciation 81.77 74.72 9.44 294.52 291.28 1.11 294.52 291.28 1.11
PBT 499.03 383.99 29.96 2432.59 1718.92 41.52 2432.59 1718.92 41.52
TAX 123.12 54.05 127.79 549.87 381.34 44.19 549.87 381.34 44.19
Deferred Tax 7.54 -31.08 -124.26 28.43 6.78 319.32 28.43 6.78 319.32
PAT 375.91 329.94 13.93 1882.72 1337.58 40.76 1882.72 1337.58 40.76
Equity 453.16 453.16 0.00 453.16 453.16 0.00 453.16 453.16 0.00
PBIDTM(%) 19.51 20.47 -4.71 23.32 23.67 -1.49 23.32 23.67 -1.49
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..